Mark Shearman Email & Phone Number
Founder
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark Shearman Location
- Newton, MA, US
Mark Shearman Work
- Founder @ Sharp Focus Consulting LLC (June 2022 - Present)
- Chief Executive Officer @ (August 2023 - November 2024)
- Advisory Board Chair @ (January 2021 - August 2023)
- Chief Scientific Officer and Executive Vice-President @ (June 2021 - March 2023)
- Chief Scientific Officer @ AGTC (Applied Genetic Technologies Corporation) [now Beacon Therapeutics] (June 2015 - June 2021)
- Senior Vice-President, Global Research and Early Development; Head Neurology Therapeutic Area @ (January 2013 - May 2015)
- Vice-President, Global Research and Early Development; Head, Multiple Sclerosis Research Platform. @ (January 2012 - December 2012)
- Vice-President, Global Head Parkinson's disease and Alzheimer's disease research; Vice-President, Head @ (August 2009 - December 2011)
- Executive Director, Boston @ Merck (January 2006 - July 2009)
- Neuroscience Site Lead, Boston @ Merck (January 2006 - July 2009)
- Alzheimer's Disease Therapeutic Area Head @ Merck (January 2004 - July 2009)
- Senior Director, Merck Sharp and Dohme Research Laboratories @ Merck (January 2004 - January 2005)
Mark Shearman Education
- Kobe University School of Medicine, Dept. of Biochemistry, Kobe, Japan
Post-Doctoral Fellow (Laboratory of Professor Yasutomi Nishizuka, FRS., Protein kinases, in particular protein kinase C)
- Max Planck Institute, Dept. of Molecular Biology, Munich, Germany
Post-Doctoral Fellow (Laboratory of Professor Axel Ullrich, c-KIT Receptor Tyrosine Kinase signal transduction)
- University of Bristol
B.Sc. (Hons) (Biochemistry)
- University of Nottingham
Ph.D. (Laboratory of Professor Philip Strange, Brain monoamine receptor signalling, with a focus on Serotonin 5-HT2 receptors)
Mark Shearman Skills
- Alzheimer's disease
- Biochemistry
- Biomarkers
- Biopharmaceuticals
- Biotechnology
- Board of Directors
- Business Development
- Business Strategy
- C Suite
- Cell & Gene Therapy
- Cell Culture
- Clinical Development
- Clinical Research
- Corporate Governance
- Decision-Making
- Drug Development
- Drug Discovery
- Drug Discovery & Development
- Executive Management
- Gene Editing
- Gene Therapy
- In Vivo
- Leadership
- Life Sciences
- Lifesciences
- Medical Diagnostics
- Multiple Sclerosis
- Neurology
- Neuroscience
- Ophthalmology
- Parkinson's disease
- Pharmaceutical Industry
- Pharmaceuticals
- Pharmacology
- R&D
- Rare Diseases
- Research
- Science
- Strategy
- Translational Medicine
- Translational Research
- Customer Service
- Molecular Biology
- SQL
- Strategic Planning
- Drug Discovery and Development
- Microsoft Excel
- Data Analysis
Mark Shearman Summary
- Mark Shearman, based in Newton, MA, US, is currently a Founder at Sharp Focus Consulting LLC. Mark Shearman brings experience from previous roles at APRINOIA Therapeutics, Editas Medicine and AGTC (Applied Genetic Technologies Corporation) [now Beacon Therapeutics]. Mark Shearman holds a Post-Doctoral Fellow in Laboratory of Professor Yasutomi Nishizuka, FRS., Protein kinases, in particular protein kinase C @ Kobe University School of Medicine, Dept. of Biochemistry, Kobe, Japan. With a robust skill set that includes Alzheimer's disease, Biochemistry, Biomarkers, Biopharmaceuticals, Biotechnology and more. Mark Shearman has 1 mobile phone numbers on RocketReach.
Looking for a different Mark Shearman?
Find contact details for 700 million professionals.
Others Named Mark Shearman
Mark Shearman
Founder
Newton, MA, US
Mark Shearman
Director
London, GB
Mark Shearman
Consultant
Brisbane, QLD, AU
Mark Shearman
Project Manager
Lowdham, GB
Mark Shearman
Senior Project Manager
St. Peters, MO, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co